HPR93 Price Evolution of Selected Cancer Immunotherapies in the US and Key European Markets

Abstract

Authors

I Jochymek A Caban K Huk

Full Text Cite This Article
Back to Volume 27, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×